NSEGeneral Updates7 Oct 2026 · 7 Oct 2026, 05:18 pm
General Updates
Alivus Life Sciences Limited · ALIVUS
✦ AI SummaryExpansion
Alivus Life Sciences Limited has acquired a 9.21% stake in Torrent Urja 19 Private Limited, a special purpose vehicle formed for setting up solar or other renewable energy projects, to comply with regulatory requirements for being a captive user under Indian electricity laws.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alivus Life Sciences Limited has informed the Exchange about announcement under Regulation 30 of SEBI (LODR), 2015 - Acquisition.
Attachments (1)
📄pdf
Download →
GLS_07102026170648_Torrent_Disclosure_Update_Signed.pdf
View document text
October 7, 2026
To, To,
Dy. General Manager The Manager – Listing,
Department of Corporate Services, National Stock Exchange of India Ltd.,
BSE Ltd., Plot No. C/1, G Block,
P. J. Towers, Dalal Street, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS
Dear Sir,
Sub: Update on acquisition of securities of Torrent Urja 19 Private Limited
This is in reference to our prior intimation dated April 2, 2025, regarding entering into Share
Purchase cum Subscription Shareholders’ Agreement and Power Supply Agreement with Torrent
Urja 19 Private Limited (SPV).
In this regard, we write to inform that the Company has acquired a 9.21% stake in the said SPV,
according to the terms and conditions of the above referenced Share Purchase cum Subscription
Shareholders’ Agreement.
Requisite disclosure required under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with relevant circulars issued thereunder, is enclosed
herewith as Annexure-A.
Request you to kindly take the same on record.
Thanking you,
Your Sincerely,
For Alivus Life Sciences Limited
(formerly Glenmark Life Sciences Limited)
Rudalf Corriea
Company Secretary & Compliance officer
Encl: as above
Alivus Life Sciences Limited ( formerly Glenmark Life Sciences Limited )
Corporate Office: Registered Office:
Technopolis Knowledge Park, A wing, 4th Floor M, ahakali Plot No 170-172, Chandramouli Industrial Estate
Caves Road, Andheri East, Mumba–i 400093, India Mohol Bazarpeth, Solapur 413 213, India
T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com
Annexure A
Disclosures/ Details of Agreement pursuant to Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 read with Schedule III and relevant circulars
issued thereunder
Sr. Particulars Details
1 Name of the target entity, details Name of the target entity:
in brief such as size, turnover etc.; Torrent Urja 19 Private Limited
Brief Details: Torrent Urja 19 Private Limited, a
subsidiary of Torrent Green Energy Private
Limited, is a special purpose vehicle formed for
purpose of setting up solar or other renewable
energy projects.
History of last 3 years turnover: Nil as of 31st
March 2026.
2 Whether the acquisition would fall Acquisition doesn’t fall within the purview of
within related party transaction(s) related party transactions.
and whether the promoter/
promoter group/ group The promoter of the Company, Nirma Limited
companies have any interest in has also entered into a similar Power Supply
the entity being acquired? If yes, Agreement and Share Purchase cum
nature of interest and details Subscription Shareholders Agreement with
thereof and whether the same is Torrent Urja 19 Private Limited whereby
done at “arm’s length”; Nirma Limited has acquired 16.99% stake in
Torrent Urja 19 Private Limited.
3 Industry to which the entity being Generation and transmission of solar energy
acquired belongs; and other sources of renewable energy.
4 Objects and impact of acquisition In line with Alivus Life Sciences Limited’s
(including but not limited to, (formerly Glenmark Life Sciences Limited)
disclosure of reasons for commitment to become carbon neutral by
acquisition of target entity, if its 2030, this investment will enhance the share of
business is outside the main line of renewable power in its operation. The
business of the listed entity) acquisition of shares will enable Alivus Life
Sciences Limited (“Alivus”) to invest in
renewable energy and thereby comply with
regulatory requirement for being a captive
user under Indian electricity laws. Alivus has
acquired 9.21% stake in Torrent Urja 19 Private
Limited in order to qualify for captive
requirements as per the provision of Electricity
Act, 2003.
5 Brief details of any governmental Not applicable
or regulatory approvals required
for the acquisition;
6 Indicative time period for The Company will invest up to an amount not
completion of the acquisition; exceeding Rs. 16 Crores by way of investment
through Equity. Out of this amount, Rs. 14.04
Crores has been invested in this transaction
resulting in the Company subscribing to 9.21%
equity shares.
7 Consideration - whether cash Cash Consideration
consideration or share swap or any
other form and details of the
same;
8 Cost of acquisition and/ or the The Company has presently invested Rs. 14.04
price at which the shares are crores, equivalent to 9.21% in the equity share
acquired; capital of the SPV.
9 Percentage of shareholding / The percentage of shareholding in the SPV is
control acquired and / or number 9.21% of the paid up equity share capital of the
of shares acquired SPV.
10 Brief background about the Brief background of the target entity:
entity acquired in terms of Torrent Urja 19 Private Limited was
products/line of business incorporated on 6 August 2024 in India and is
acquired, date of incorporation, engaged in business of generating, producing,
history of last 3 years turnover, accumulating, storing, improving, buying,
country in which the acquired selling, reselling, transmitting, distributing and
entity has presence and any other supplying electrical power generated using
significant information (in brief) solar energy and all other sources of renewable
energy and developing infrastructure projects
based on non-conventional renewable sources
of energy in both grid – connected as well as
off-grid mode (distributed generation) and/ or
related assets or products or activities like
Non-conventional Energy generation and
transmission and to act as agent,
representative, consultant, collaborator or
otherwise to deal in electrical power.
History of last 3 years turnover: NIL
Country: India